Significant increase in prostaglandin E-major urinary metabolite with physical exercise suggesting muscle inflammation

References

• Arai Y, Arihiro S, Matuura T, et al. 2014. Prostaglandin E-major urinary metabolite as a reliable surrogate marker for mucosal inflammation in ulcerative colitis. Inflamm Bowel Dis. 20:1208–1216.
   PubMed Web of Science ®Google Scholar
• Buford TW, Cooke MB, Shelmadine BD, et al. 2009a. Effects of eccentric treadmill exercise on inflammatory gene expression in human skeletal muscle. Appl Physiol Nutr Metab. 34:745–753.
   PubMed Web of Science ®Google Scholar
• Buford TW, Cooke MB, Willoughby DS. 2009b. Resistance exercise-induced changes of inflammatory gene expression within human skeletal muscle. Eur J Appl Physiol. 107:463–471.
   PubMed Web of Science ®Google Scholar
• Conceição MS, Libardi CA, Nogueira FR, et al. 2012. Effects of eccentric exercise on systemic concentrations of pro- and anti-inflammatory cytokines and prostaglandin (E2): comparison between young and postmenopausal women. Eur J Appl Physiol. 112:3205–3213.
   PubMed Web of Science ®Google Scholar
• Ferreira SH, Vane JR. 1967. Prostaglandins: their disappearance from and release into the circulation. Nature. 216:868–873.
   PubMed Web of Science ®Google Scholar
• Fujiwara M, Okayasu I, Oritsu M, et al. 2000. Significant increase in prostaglandin E-main urinary metabolite by laxative administration: comparison with ulcerative colitis. Digestion. 61:201–206.
   PubMed Web of Science ®Google Scholar
• Hagiwara SI, Okayasu I, Fujiwara M, et al. 2017. Prostaglandin E-major urinary metabolite as a biomarker for pediatric ulcerative colitis activity. J Pediat Gastroenterol Nutr. 64:955–961.
   PubMed Web of Science ®Google Scholar
• Horikiri T, Hara H, Saito N, et al. 2017. Increased levels of prostaglandin E−major urinary metabolite (PGE-MUM) in chronic fibrosing interstitial pneumonia. Respir Med. 122:43–50.
   PubMed Web of Science ®Google Scholar
• Inagawa T, Imaki K, Masuda H, et al. 1983. Simplified immunoassays of prostaglandin E main metabolite in human urine. Adv Prostaglandin, Thromboxane, Leukotriene Res. 11:191–196.
   PubMedGoogle Scholar
• Kanda K, Sugama K, Hayashida H, et al. 2013. Eccentric exercise-induced delayed-onset muscle soreness and changes in markers of muscle damage and inflammation. Exerc Immunol Rev. 19:72–85.
   PubMed Web of Science ®Google Scholar
• Katagiri N, Wakabayasi M, Arihiro S, et al. 2017. Development of fully automated chemiluminescent enzyme immunoassay system for measurement of prostaglandin E major urinary metabolites (PGE-MUM). JJCLA (Nippon kensajidouka gakkai kaishi). 42:584–590. in Japanese with English abstract.
   Google Scholar
• Liu SZ, Jemiolo B, Lavin KM, et al. 2016. Prostaglandin E2/cyclooxygenase pathway in human skeletal muscle: influence of muscle fiber type and age. J Appl Physiol. 120:546–551.
   PubMed Web of Science ®Google Scholar
• MacNicol JL, Lindinger MI, Pearson W. 2018. A time-course evaluation of inflammatory and oxidative markers following high-intensity exercise in horses: a pilot study. J Appl Physiol. 124:860–865.
   PubMed Web of Science ®Google Scholar
• Madruga Dias JA, Rosa RS, Perpétuo, I. et al. 2014. Pachydermoperiostosis in an African patient caused by a Chinese/Japanese SLCO2A1 mutation—Case report and review of literature. Semin Arthritis Rheum. 43:566–569.
   PubMed Web of Science ®Google Scholar
• Morris PG, Zhou XK, Milne GL, et al. 2013. Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer. Cancer Prevention Research. 6:428–436.
   PubMed Web of Science ®Google Scholar
• Okayasu I, Kuroiwa H, Shinkawa K, et al. 2022. Higher prostaglandin E-major urinary metabolite levels in male versus female students and a small decrease during the menstrual cycle. Kitasato Med J. 52(2):81–89.
   Google Scholar
• Okayasu I, Ohnishi H, Sarandi I, et al. 2014. Significant increase of prostaglandin E-major urinary metabolite in male smokers: a screening study of age and gender differences using a simple radioimmunoassay. J Clin Lab Anal. 28:32–41.
   PubMed Web of Science ®Google Scholar
• Paulsen G, Egner IM, Drange M, et al. 2010. A COX-2 inhibitor reduces muscle soreness, but does not influence recovery and adaptation after eccentric exercise. Scand J Med Sci Sports. 20:e195–e207.
   PubMed Web of Science ®Google Scholar
• Paulsen G, Mikkelsen UR, Raastad T, et al. 2012. Leucocytes, cytokines and satellite cells: what role do they play in muscle damage and regeneration following eccentric exercise? Exerc Immunol Rev. 18:42–97.
   PubMed Web of Science ®Google Scholar
• Peake JM, Neubauer O, Della Gatta PA, et al. 2017. Muscle damage and inflammation during recovery from exercise. J Appl Physiol. 122:559–570.
   PubMed Web of Science ®Google Scholar
• Pereira C, Queirós S, Galaghar A, et al. 2016. Influence of genetic polymorphisms in prostaglandin E2 pathway (COX-2/HPGD/SLCO2A1/ABCC4) on the risk for colorectal adenoma development and recurrence after polypectomy. Clin Transl Gastroenterol. 7:e191.
   PubMed Web of Science ®Google Scholar
• Poortman JR, Blommaert E, Baptista M, et al. 1997. Evidence of differential renal dysfunctions during exercise in men. Eur J Appl Physiol. 76:88–91.
   Web of Science ®Google Scholar
• Poortmans JR, Brauman H, Staroukine M, et al. 1988. Indirect evidence of glomerular/tubular mixed-type postexercise proteinuria in healthy humans. Am J Physiol. 254:F277–F283.
   PubMedGoogle Scholar
• Sakurai T, Akita Y, Miyashita H, et al. 2022. Prostaglandin E-major urinary metabolite fiagnoses mucosal healing in patients with ulcerative colitis in remission phase. J Gastroenterol Hepatol. 2022, Jan 22. doi:10.1111/jgh.15782. On line ahead of print.
   Web of Science ®Google Scholar
• Schrezenmeier EV, Barasch J, Budde K, et al. 2017. Biomarkers in acute kidney injury - pathophysiological basis and clinical performance. Acta physiologica. 219:554–572.
   PubMed Web of Science ®Google Scholar
• Uppal S, Diggle CP, Carr IM, et al. 2008. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet. 40:789–793.
   PubMed Web of Science ®Google Scholar
• Yuan L, Chen L, Liao RX, et al. 2015. A common mutation and a novel mutation in the HPGD gene in nine patients with primary hypertrophic osteoarthropathy. Calcif Tissue Int. 97:336–342.
   PubMed Web of Science ®Google Scholar